Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 968430, 6 pages
http://dx.doi.org/10.1155/2014/968430
Research Article

Attitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors

1Department of Pharmacology, All India Institute of Medical Sciences, Sijua, Bhubaneswar, Odisha 751019, India
2Department of Pharmacology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi 110029, India

Received 29 August 2014; Revised 29 October 2014; Accepted 5 November 2014; Published 19 November 2014

Academic Editor: P. Ravi Shankar

Copyright © 2014 Biswa Mohan Padhy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Ramser, L. R. Sprabery, G. L. Hamann, C. M. George, and A. Will, “Results of an intervention in an academic internal medicine clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change,” Journal of Managed Care Pharmacy, vol. 15, no. 4, pp. 344–350, 2009. View at Google Scholar · View at Scopus
  2. J. J. Heidelbaugh, K. L. Goldberg, and J. M. Inadomi, “Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected],” The American Journal of Gastroenterology, vol. 104, supplement 2, pp. S27–S32, 2009. View at Publisher · View at Google Scholar
  3. S. M. Eid, A. Boueiz, S. Paranji, C. Mativo, B. A. Regina Landis, and M. S. Abougergi, “Patterns and predictors of proton pump inhibitor overuse among academic and non-academic hospitalists,” Internal Medicine, vol. 49, no. 23, pp. 2561–2568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Brooks, “Top 100 Most Prescribed, Top Selling Drugs,” Medscape Medical News, May 2014, http://www.medscape.com/viewarticle/825053.
  5. S. C. Nasser, J. G. Nassif, and H. I. Dimassi, “Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients,” World Journal of Gastroenterology, vol. 16, no. 8, pp. 982–986, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Mullin, M. Gabello, L. J. Murray et al., “Proton pump inhibitors: actions and reactions,” Drug Discovery Today, vol. 14, no. 13-14, pp. 647–660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Yip and A. Mahal, “The health care systems of China and India: performance and future challenges,” Health Affairs, vol. 27, no. 4, pp. 921–932, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. E. Lacy, M. D. Crowell, R. P. Riesett, and A. Mitchell, “Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior,” Journal of Clinical Gastroenterology, vol. 39, no. 6, pp. 489–494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Lanas, J. V. Esplugues, J. Zapardiel, and E. Sobreviela, “Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications,” World Journal of Gastroenterology, vol. 15, no. 47, pp. 5953–5959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. F. Barrison, L. A. Jarboe, B. M. Weinberg, K. Nimmagadda, L. M. Sullivan, and M. M. Wolfe, “Patterns of proton pump inhibitor use in clinical practice,” The American Journal of Medicine, vol. 111, no. 6, pp. 469–473, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. M. Taylor, N. Walsham, S. E. Taylor, and L. Wong, “Use and toxicity of complementary and alternative medicines among emergency department patients,” EMA—Emergency Medicine Australasia, vol. 16, no. 5-6, pp. 400–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. E. B. Kulstad, R. Sikka, R. T. Sweis, K. M. Kelley, and K. H. Rzechula, “ED overcrowding is associated with an increased frequency of medication errors,” The American Journal of Emergency Medicine, vol. 28, no. 3, pp. 304–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Gupta, S. Malhotra, K. K. Chandra, N. Sharma, and P. Pandhi, “Utilization of parenteral anti-infective agents in the medical emergency unit of a tertiary care hospital: an observational study,” Pharmacoepidemiology and Drug Safety, vol. 13, no. 9, pp. 653–657, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. K. J. Patel, M. S. Kedia, D. Bajpai, S. S. Mehta, N. A. Kshirsagar, and N. J. Gogtay, “Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study,” BMC Clinical Pharmacology, vol. 7, article 8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Janicki and S. Stewart, “Stress-ulcer prophylaxis for general medical patients: a review of the evidence,” Journal of Hospital Medicine, vol. 2, no. 2, pp. 86–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Tsumura, I. Tamura, H. Tanaka et al., “Prescription of nonsteroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan,” Internal Medicine, vol. 46, no. 13, pp. 927–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Lanas, J. V. Esplugues, J. Zapardiel, and E. Sobreviela, “Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications,” World Journal of Gastroenterology, vol. 15, no. 47, pp. 5953–5959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Balakrishnan and R. Jhaj, “Prophylactic use of gastro-protective agents in patients on low-dose aspirin,” British Journal of Clinical Pharmacology, vol. 65, no. 4, pp. 621–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. G. G. Kaplan, D. Bates, D. Mcdonald, R. Panaccione, and J. Romagnuolo, “Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions,” Clinical Gastroenterology and Hepatology, vol. 3, no. 12, pp. 1207–1214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. G. Hoover, A. L. Schumaker, and K. J. Franklin, “Use of intravenous proton-pump inhibitors in a teaching hospital practice,” Digestive Diseases and Sciences, vol. 54, no. 9, pp. 1947–1952, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. T. White, I. M. Storch, and G. E. Mullin, “Intravenous pantoprazole: physician understanding of indications and their prescribing patterns leading to hospital restrictions,” The American Journal of Gastroenterology, vol. 98, p. S231, 2003. View at Google Scholar
  22. E. S. Lang, “Intravenous proton pump inhibitors prior to endoscopy in suspected upper gastrointestinal bleeding,” Canadian Journal of Emergency Medicine, vol. 10, no. 3, pp. 244–246, 2008. View at Google Scholar · View at Scopus
  23. A. Sreedharan, J. Martin, G. I. Leontiadis et al., “Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding,” Cochrane Database of Systematic Reviews, vol. 7, Article ID CD005415, 2010. View at Google Scholar
  24. D. G. N. Craig, R. Thimappa, V. Anand, and S. Sebastian, “Inappropriate utilization of intravenous proton pump inhibitors in hospital practice—a prospective study of the extent of the problem and predictive factors,” An International Journal of Medicine, vol. 103, no. 5, Article ID hcq019, pp. 327–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Afif, R. Alsulaiman, M. Martel, and A. N. Barkun, “Predictors of inappropriate utilization of intravenous proton pump inhibitors,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 5, pp. 609–615, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. K. Law, C. N. Andrews, and R. Enns, “Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use,” Gastrointestinal Endoscopy, vol. 69, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. M. Shivkar, “Clinical information in drug package inserts in India,” Journal of Postgraduate Medicine, vol. 55, no. 2, pp. 104–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. H. S. Khara and C. S. Pitchumoni, “Proton pump inhibitors: a better prescription is needed,” Journal of Clinical Gastroenterology, vol. 43, no. 6, pp. 597–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Hussain, M. Stefan, P. Visintainer, and M. Rothberg, “Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?” Southern Medical Journal, vol. 103, no. 11, pp. 1103–1110, 2010. View at Publisher · View at Google Scholar · View at Scopus